EverQuote looks like a good buy right now for a beginner long-term investor with $50,000-$100,000 to invest. The stock just delivered a strong Q1 beat and raise, pre-market price is holding near 21 after a sharp post-earnings move, and the technical trend remains constructive. Wall Street remains mostly bullish, hedge funds are accumulating, and the company’s latest quarter showed solid growth in revenue, earnings, and margins. I would rate it a buy rather than a hold because the current setup still supports upside and the investor is unwilling to wait for a perfect entry.
EVER is in an uptrend after the earnings-driven surge. MACD histogram is positive and expanding, which supports bullish momentum. RSI_6 at 65.1 shows strength but is not yet extreme. Moving averages are converging, suggesting the stock may be consolidating after a strong move rather than reversing. Price is above the pivot at 18.36 and below resistance at 22.22, so the current level around 21 is near the upper part of the recent range but still has room toward R1 and R2. Overall technicals favor continuation more than breakdown.

["Q1 earnings beat with EPS of $0.51 and revenue of $190.85M, both above expectations", "Q1 revenue rose 14.54% YoY, net income rose 133.70% YoY, and EPS grew 142.86% YoY", "Adjusted EBITDA and profitability trends improved meaningfully, showing operating leverage", "JPMorgan recently raised its price target to $24 and kept Overweight after a clean beat and raise", "Hedge funds are buying, with buying amount up 158.11% over the last quarter", "Bullish options positioning with low put-call ratios", "Pre-market price near 21 indicates the market is still supporting the earnings move"]
["Insiders are selling heavily, with selling amount up 681.94% over the last month", "Raymond James cut its target to $18, showing some caution despite an Outperform rating", "The stock has already had a sharp post-earnings jump, so some of the easy upside may be priced in", "No AI Stock Picker or SwingMax signal is present today"]
Latest quarter: Q1 2026. EverQuote reported strong growth with revenue up 14.54% YoY to $190.85M, net income up 133.70% YoY to $18.67M, and EPS up 142.86% YoY to $0.51. Gross margin improved to 97.77%, indicating very strong operating efficiency. This was a clear growth quarter with better profitability and no sign of deterioration in the core business.
Analyst sentiment is mostly positive, though targets have come down recently. JPMorgan raised its target to $24 from $22 and kept Overweight after the beat-and-raise quarter. Earlier in the year, JPMorgan, B. Riley, Needham, Canaccord, and Raymond James all cut targets, mainly reflecting valuation resets and some caution around 2026 growth/AI-disruption concerns, but most kept Buy/Overweight/Outperform ratings. The Wall Street pros view is still constructive overall: strong earnings, durable growth, and margin expansion are the bullish points, while the bearish side focuses on slower future growth, AI concerns, and lower revised targets.